Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Environ Res. 2019 Dec 31;182:109101. doi: 10.1016/j.envres.2019.109101

Table 3b.

Percentage change in infant serum concentrations of DHEAS and 17-hydroxyprogesterone (17-OHP) during mini puberty for a two-fold increase in maternal serum PFAA concentrations

Compound (ng/mL) DHEAS
17-OHP
All (N=373) Girls (N=165) Boys (N=208) All (N=373) Girls (N=165) Boys (N=208)


% Change (95 % CI) % Change (95 % CI) % Change (95 % CI) % Change (95 % CI) % Change (95 % CI) % Change (95 % CI)
PFHxS (ng/mL)
 Crude a 7.0 (−3.5; 18.6) 4.9 (−10.8; 23.2) 8.5 (−5.2; 24.3) 1.7 (−5.0, 8.9) −2.2 (−11.9, 8.7) 4.4 (−4.4, 14.0)
 Adjusted b 5.2 (−5.5; 17.0) 2.9 (−12.7, 21.1) 6.8 (−6.9, 22.5) 1.1 (−5.7, 8.4) −2.8 (−12.6, 8.2) 3.9 (−5.0, 13.6)
PFOS (ng/mL)
 Crude a 0.4 (−13.6; 16.8) −8.3 (−26.7; 14.7) 8.1 (−11.8; 32.4) 2.6 (−7.1, 13.4) 2.7 (−11.2, 18.8) 3.0 (−9.7; 17.6)
 Adjusted b −2.1 (−16.0; 14.1) −10.4 (−28.4, 12.2) 5.3 (−14.2, 29.3) 2.2 (−7.5, 12.9) 2.1 (−11.9, 18.2) 2.3 (−10.5, 17.0)
PFOA (ng/mL)
 Crude a −0.2 (−11.0, 11.8) 5.9 (−10.0, 24.6) −5.5 (−19.3, 10.7) 3.5 (−4.0, 11.5) 3.9 (−6.5, 15.5) 2.4 (−7.6, 13.5)
 Adjusted b −5.1 (−16.3, 7.7) 0.4 (−15.5, 19.3) −9.9 (−23.7, 6.4) 2.3 (−5.8, 11.0) 3.0 (−7.9, 15.2) 1.6 (−8.8, 13.2)
PFNA (ng/mL)
 Crude a −2.6 (−16.0, 13.0) −1.5 (−21.3, 23.4) −3.4 (−20.8, 17.7) 2.6 (−7.0, 13.1) 3.9 (−10.2, 20.2) 1.6 (−10.6, 15.5)
 Adjusted b −5.5 (−18.8, 10.0) −5.4 (−24.8, 18.9) −5.6 (−22.6, 15.2) 1.8 (−7.8, 12.4) 2.8 (−11.4, 19.4) 1.0 (−11.2, 15.0)
PFDA (ng/mL)
 Crude a −11.1 (−24.1, 4.1) −16.0 (−35.0, 8.8) −7.7 (−24.1, 12.1) −1.6 (−11.4, 9.2) −5.5 (−20.1, 11.8) 0.7 (−11.5, 14.7)
 Adjusted b −12.3 (−25.1, 2.7) −18.9 (−37.5, 5.2) −8.3 (−24.8, 11.9) −2.1 (−11.7, 8.6) −6.5 (−21.2, 10.8) 0.6 (−11.6, 14.6)

Note: CI, Confidence interval; DHEA, dehydroepiandrosterone; DHEAS, Dehydroepiandrosterone-sulfate; PFDA, Perfluorodecanoic acid; PFHxS, Perfluorohexane sulfonic acid; PFOA, Perfluorooctanoic acid; PFOS, Perfluorooctane sulfonic acid; PFNA, Perfluorononanoic acid

a

Adjusted for age of the child at examination time.

b

Adjusted for age of the child at examination time, maternal parity, and sex of the child (not in sex-specific analyses).

*

p-value<0.05